Medicines regulator approves UK’s first dual combination inhaler for mild asthma AstraZeneca said the marketing authorisation meant its Symbicort Turbohaler 200/6 could be used by 2.7 million adults in the UK who live with mild asthma.…
More than 20,000 inhalers returned through postal inhaler recycling scheme The scheme has saved an estimated 119.3 tonnes of carbon dioxide emissions entering the atmosphere.…
Community pharmacies incentivised to refer frequent users of reliever inhalers to general practice The new referral incentive will be part of the Pharmacy Quality Scheme for 2022/2023.…
NHS Scotland announces plan to switch patients to greener inhalers A strategy document, published by NHS Scotland, says that improvements in the way asthma and chronic obstructive pulmonary disease are managed could help reduce metered dose inhaler use.…
Best practice principles for inhaler prescribing How to select appropriate inhaler devices that balance the need to personalise treatment and optimise disease control while reducing the environmental impact of prescribing.…
More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
NHS develops dashboard to identify possible over-prescribing of prednisolone The dashboard calculates the total cumulative dose of prednisolone prescribed to patients in England in the past 12 months, allowing those at risk to be considered for alternative treatment methods.…
More than 90% of lung disease patients say community pharmacy services are vital, survey finds Results of a survey by the Taskforce for Lung Health found that patients valued community pharmacies because they are close to home, there is no need to make an appointment and they have convenient opening times.…
